Safety and effectiveness of dupilumab in the real‐world treatment of atopic dermatitis in Japan: 1‐year interim analysis from a post‐marketing surveillance.

Autor: Saeki, Hidehisa1, Fujita, Hiroyuki2, Suzuki, Katsuhisa2, Arima, Kazuhiko2 kazuhiko.arima@sanofi.com
Zdroj: Journal of Cutaneous Immunology & Allergy. Jun2023, Vol. 6 Issue 3, p78-87. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje